Key result
Cognitive and pharmacological interventions improve memory in review, but lack a clear gold standard.
Why the study?
Alcohol-related cognitive impairment is highly prevalent and negatively influences treatment outcomes but remains underdiagnosed and undertreated, with unclear evidence on effective interventions.
Do neuropsychological and pharmacological interventions improve cognitive function in patients with alcohol-related cognitive impairment?
Systematic Review (n=26)
Do neuropsychological and pharmacological interventions improve cognitive function in patients with alcohol-related cognitive impairment?
While several cognitive and pharmacological interventions show promise for alcohol-related cognitive impairment, current evidence is insufficient to recommend a gold-standard treatment.
Supports interim clinical consideration of cognitive or pharmacological approaches; leaves open identification of optimal regimens pending rigorous trials.
Alcohol-related cognitive impairment (ARCI) is highly prevalent among patients with alcohol dependence. Although it negatively influences treatment outcome, this condition is underdiagnosed and undertreated. The aim of this systematic review is to investigate the existing evidence regarding both cognitive and pharmacological interventions for ARCI. We systematically reviewed PubMed, Scopus and Science direct databases up to May 2019 and followed the PRISMA guidelines. The quality of the studies was assessed using the Jadad Scale. Twenty-six studies were eligible for inclusion (14 referring to neuropsychological interventions and 12 to pharmacological treatments). Among neuropsychological interventions, computerised treatments, errorless learning and component method showed positive effects on working memory, memory measures and general cognitive function. On the other hand, thiamine, memantine and methylphenidate improved working memory, long-term memory and general cognitive function. Nevertheless, these studies have several limitations, such as small sample size, lack of replication of the results or low specificity of the interventions. Therefore, no gold-standard intervention can yet be recommended for clinical practice, and further research based on promising strategies (e.g. digital interventions, thiamine) is required.
No takes yet. Share an insight, caveat, or question.
Caballería et al. (2020) conducted a systematic review in Alcohol-related cognitive impairment (n=26). Cognitive and pharmacological interventions was evaluated on Working memory, long-term memory and general cognitive function. Cognitive and pharmacological interventions showed positive effects on memory and cognitive function across 26 studies, but no gold-standard can be recommended due to methodological limitations.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: